Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) infection is a promising approach for cancer therapy. In this study we describe the establishment of a new preclinical model of feline mammary carcinoma (FMC) using a recently established cancer cell line, DT09/06. In addition, we evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Adelfinger, Marion, Gentschev, Ivaylo, Grimm de Guibert, Julio, Weibel, Stephanie, Langbein-Laugwitz, Johanna, Härtl, Barbara, Escobar, Hugo Murua, Nolte, Ingo, Chen, Nanhai G., Aguilar, Richard J., Yu, Yong A., Zhang, Qian, Frentzen, Alexa, Szalay, Aladar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122492/
https://www.ncbi.nlm.nih.gov/pubmed/25093734
http://dx.doi.org/10.1371/journal.pone.0104337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122492/
https://www.ncbi.nlm.nih.gov/pubmed/25093734
http://dx.doi.org/10.1371/journal.pone.0104337

Ejemplares similares